NEW RELATIONSHIPS ADDRESS KEY MARKETS IN EUROPE, ASIA, THE MIDDLE EAST AND LATIN AMERICA

RANCHO CORDOVA, Calif., July 24 /PRNewswire-FirstCall/ -- ThermoGenesis Corp., (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells, said today that it has added 10 new distributors for its BioArchive System covering a number of key geographies outside the U.S. Three of the distributors will also have the rights for the Company's AutoXpress(TM) (AXP(TM)) Platform. The BioArchive is used for cryopreserving and archiving of stem cells and tissue, while the AXP is used for harvesting stem cells in a closed system from umbilical cord blood.

The addition of these new distributors follows the Company's announcement in May that it had restructured its international distribution agreement with GE Healthcare (GEHC) effective July 1, 2008. GEHC returned worldwide rights to distribute the BioArchive System to ThermoGenesis, while continuing as exclusive distributor of AXP Platform products for cord blood applications in geographies outside of South America, Central America, Russia and China -- excluding Hong Kong and Taiwan.

The markets covered under these new BioArchive distribution agreements include the United Kingdom, Russia, the Baltic region, China, Hong Kong, South Korea, a number of Middle Eastern and African countries and Central and South America. In addition, the agreements add AXP distributors in Russia, China, and Central and South America. ThermoGenesis will sell the BioArchive direct in North America.

'Our ability to achieve these agreements in a short period of time speaks not only to the effectiveness of our sales organization, but also to the potential market opportunity for our offerings,' noted Dr.